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Pregnant women are advised to abstain from alcohol despite insufficient evidence on the fetal consequences
of moderate prenatal alcohol use. Mendelian randomization could help distinguish causal effects from arti-
facts due to residual confounding and measurement errors; however, polymorphisms reliably associated
with alcohol phenotypes are needed. We aimed to test whether alcohol dehydrogenase (ADH) gene variants
were associated with alcohol use before and during pregnancy. Ten variants in four ADH genes were geno-
typed in women from South-West England. Phenotypes of interest were quantity and patterns of alcohol con-
sumption before and during pregnancy, including quitting alcohol following pregnancy recognition. We
tested single-locus associations between genotypes and phenotypes with regression models. We used
Bayesian models (multi-locus) to take account of linkage disequilibrium and reanalyzed the data with further
exclusions following two conservative definitions of ‘white ethnicity’ based on the woman’s reported parental
ethnicity or a set of ancestry-informative genetic markers. Single-locus analyses on 7410 women of white/
European background showed strong associations for rs1229984 (ADH1B). Rare allele carriers consumed
less alcohol before pregnancy [odds ratio (OR) 5 0.69; 95% confidence interval (CI): 0.56–0.86, P 5 0.001],
were less likely to have ‘binged’ during pregnancy (OR 5 0.55, 95% CI: 0.38–0.78, P 5 0.0009), and more
likely to have abstained in the first trimester of gestation (adjusted OR 5 1.42, 95% CI: 1.12–1.80, P 5
0.004). Multi-locus models confirmed these results. Sensitivity analyses did not suggest the presence of
residual population stratification. We confirmed the established association of rs1229984 with reduced alco-
hol consumption over the life-course, contributing new evidence of an effect before and during pregnancy.
INTRODUCTION
Whereas the fetal consequences of heavy alcohol intake during
pregnancy have been clear for some time (1), the effect of
moderate drinking remains controversial (2). The advice to
pregnant women is generally to abstain, since no amount of
alcohol is known to be safe (3). However, this is based on a
precautionary principle rather than on solid evidence. Even
where associations have been confirmed, these have generally
been weak (4) and could still be due to residual confounding
(5,6) and under-reporting of prenatal alcohol use (7,8). Both
of these potentially interfere with establishing causality
of the associations of maternal alcohol intake with various
outcomes [from fetal growth and neurodevelopment (9) to
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childhood mental health problems such as hyperactivity or
inattention (10) or conduct disorder (11)] and deriving
evidence-based messages for the public.
Genetic variants associated with alcohol intake or metab-
olism have been proposed as unbiased and unconfounded
markers of the effect of ingested ethanol or its metabolites
(acetate, acetaldehyde)—an approach known as Mendelian
randomization (12,13). A single nucleotide polymorphism
(SNP) exists in the acetaldehyde dehydrogenase gene
ALDH2, which encodes an enzyme unable to clear acet-
aldehyde and often causes individuals carrying the variant to
abstain from alcohol or drink in moderation (14). The use of
ALDH2 as an instrument has proved valuable in Mendelian
randomization studies (15,16). However, the potential rel-
evance of this variant is limited to East-Asian populations as
it is absent in populations of European origin (17).
Identifying suitable instrument for Mendelian randomiz-
ation studies of the consequences of prenatal alcohol exposure
in European populations remains a challenge. The most
natural choice of candidates is alcohol dehydrogenase (ADH)
genes, which catalyze the first step of alcohol metabolism
oxidizing ethanol into acetaldehyde. A role for these variants
in alcohol intake, metabolism and dependence has been
suggested by both genome-wide linkage (18–21) and
candidate gene (22–25) studies, and in particular a non-
synonymous variant in ADH1B has been implicated. The
rare variant is thought to encode an enzyme which accelerates
ethanol clearance (26) (based on studies in vitro), but there is
limited evidence for association with alcohol metabolism
in vivo (22,27,28,29). The extent to which this SNP is associ-
ated with alcohol intake among pregnant women is unclear.
On the one hand, the pressures to cut down or quit drinking
alcohol (30–32) might increase the relative contribution of
genetic variation to alcohol intake and, on the other; preg-
nancy might result in metabolic changes and modify the
effect of the ADH1B and other ADH variants. A systematic
review on the incidence of fetal alcohol syndrome in popu-
lations of European and African origins found that this SNP
was associated with offspring outcome (33), but highlighted
the need to better understand the extent to which the
ADH1B variant is associated with prenatal alcohol use (33).
This study seeks to validate genetic polymorphisms in ADH
genes, including ADH1B, as instruments for prenatal alcohol
exposure, by testing first, whether they predict maternal
alcohol intake and patterns of consumption just before and
during pregnancy, and second, whether the variants related
to alcohol intake are also associated with the likelihood of
abstaining from alcohol during pregnancy.
To answer these questions, we analyzed data from mothers
of white ethnic origin enrolled in the Avon Longitudinal Study
of Parents and Children (ALSPAC).
RESULTS
A description of selected participants’ characteristics is pre-
sented in Table 1. Of the 14 541 pregnant women enrolled
in ALSPAC initially, 7410 could be included in the present
analysis. Details of exclusions from the study are reported in
Supplementary Material, Fig. S1. Genotype frequencies were
similar among those who completed and did not complete
the questionnaire (data not shown).
Genotype distributions were compatible with no departure
from Hardy–Weinberg equilibrium for all SNPs except
rs4699714 (ADH4) (Supplementary Material, Table S2). Gen-
otyping success rate was above 93.3% and error rate from
duplicates was below 0.25% for all SNPs.
A summary of single-locus association tests between ADH
genotypes and three dimensions of alcohol drinking before
and during pregnancy is presented in Figure 1, where inverse-
logged P-values are plotted against each SNP’s chromosomal
position. The ‘peak’ corresponds to a SNP in ADH1B,
rs1229984, for which there is evidence of association with
average alcohol intake before (P-value ¼ 0.001) and binge
drinking during pregnancy (P-value ¼ 9  1024) (Fig. 1 and
Table 2). There is also some evidence of association
between rs2866151 (ADH1A) and weekly drinking before
pregnancy (P-value ¼ 0.006) (Fig. 1 and Table 2). In
general, the associations are stronger when considering drink-
ing before the index pregnancy, and attenuate for drinking
during the period following recognition of pregnancy, in par-
ticular average weekly drinking in the first trimester (Table 2).
In order to account for linkage disequilibrium (LD) in the
area (Fig. 2), which could confound association results, Baye-
sian multilocus models were fitted to these data, separately for
the three alcohol measures. Figures in Supplementary
Material, Table S3 represent the probability that a model
with one or more SNPs as explanatory variables is selected
out of all the possible models in the model space (statistics
based on 10 000 iterations with the first 5000 excluded—
‘burn-in’). Results show a strong effect of rs1229984 on
alcohol drinking before pregnancy and binge drinking during
pregnancy, independent on the other SNPs in the model.
However, for one of the outcomes, drinking in the first trime-
ster of pregnancy, the model with rs1229984 performed worse
than the null model (posterior probabilities: 0.08 versus 0.88)
(Supplementary Material, Table S3). The association between
rs2866151 and pre-pregnancy drinking disappears when taking
into account LD patterns in this multi-locus model. These
results are in line with crude associations from classical uni-
variable analyses (Table 2), confirming that the only SNP
associated with alcohol use in this study is the established
Table 1. Selected participants’ characteristics
Na Mean (SD) or %
Age at delivery (years) 7410 28 (5)
BMI before pregnancy (kg/m2) 6594 23.0 (3.9)
Secondary level education at most (versus higher) 6986 64%
Manual worker (versus more qualified occupation)b 6594 51%
Smoking pre-pregnancy (yes versus no) 7344 32%
Drinking before pregnancy (yes versus no) 7410 93%
Drinking in first trimester of pregnancy
(yes versus no)
7387 55%
Binge drinking during pregnancy (yes versus no)c 7365 17%
aNumber with complete data.
bOn the basis of the highest occupation held either by the woman or her partner
(see Materials and Methods for details).
cAt week 18 of gestation.
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rs1229984, but also that actual weekly intake during the first
trimester is the only outcome that does not seem to be associ-
ated with genotypes.
Additional results for rs1229984 are presented in detail in
Table 3. The strong evidence for association between this
SNP and average intake before pregnancy but not during preg-
nancy, and the result showing that it predicts abstention in
pregnancy but not before (Table 3), prompted us to investigate
whether the variant was associated with the likelihood of
drinking cessation in pregnancy. There is strong evidence
that women carrying the rare A allele were more likely to
quit alcohol during the first trimester of pregnancy [odds
ratio (OR): 1.52; 95% confidence interval (CI): 1.22, 1.91;
P-value ¼ 0.0004) (Table 4). The evidence remains after
adjusting for pre-pregnancy alcohol consumption (P-value ¼
0.004). Weaker evidence is found when looking at the odds
of quitting at later stages of gestation, around week 18 and
week 32, and these associations seem to be entirely explained
by pre-pregnancy intake (Table 4).
The associations between rs1229984 and maternal charac-
teristics known to be generally related to alcohol drinking
were analyzed to empirically assess the specificity of the
rs1229984-alcohol intake association. For maternal socio-
economic status or education, smoking habits, BMI and age
at delivery there is no evidence of association; nor is there
any association with alcohol drinking behavior of the partner
(Supplementary Material, Table S4). Similarly, since drinking
cessation in the first trimester may be due to symptoms of
nausea and various food aversions experienced in early preg-
nancy, we looked at these in association with rs1229984 gen-
otype. There is little evidence of association with nausea or
developing aversion to any of the following: coffee, tea,
colas or cigarettes (Supplementary Material, Table S5).
Among women included in the analysis as ‘white’, 36 reported
ethnicity other than white for their mother, father or both.
After excluding these in sensitivity analyses, results were
largely unchanged (data not shown). Further exclusions based
on a set of ancestry-informative genetic markers (N ¼ 76
women), or on self-reported Jewish faith (as proxy for Jewish
ancestry/ethnicity) (N ¼ 4) did not alter the results (not
shown—see Materials and Methods for details).
DISCUSSION
Summary of results
We selected 10 candidate polymorphisms in four ADH genes
and found evidence for a strong inverse association between
the A allele of the non-synonymous variant rs1229984 in
ADH1B and alcohol drinking before pregnancy and binge
drinking patterns during pregnancy. Further analyses
suggested a role for this variant in predicting drinking cessa-
tion particularly in the first trimester. Since the strongest pre-
dictor of drinking cessation during pregnancy is alcohol
consumption before pregnancy (34,35), we repeated the ana-
lyses adjusting for this covariate potentially on the causal
pathway, and the evidence remained strong, although there
is a small chance that this could still be due to residual con-
founding, i.e. our inability to capture drinking behaviors
with more precision.
This is the first study, to our knowledge, on the role of ADH
variants on alcohol drinking in women just before and during
pregnancy. Strong external pressures exist for pregnant
women to modify their behavior and quit alcohol (30–32).
Such pressures might highlight any existing genetic com-
ponent to drinking behavior, through homogenization of
some of the concurrent social determinants of alcohol drink-
ing. However, the extreme-case scenario is that they could
result into everybody abstaining from alcohol regardless of
their genotype, thus overriding genetic effects. Indeed, we
found that carriers of the rs1229984 A allele (ADH1B), who
before pregnancy were both more likely to abstain and drink
less on average, during pregnancy and in particular in the
first trimester, were still drinking less, and they were less
likely to binge drink and more likely to have stopped drinking
altogether. This supports the use of the rs1229984 variant as a
candidate instrument for alcohol drinking (versus very little or
no drinking) around the time of conception and even more so
for binge drinking during pregnancy. This instrument would
be highly specific to alcohol behavior, however, the population
attributable risk is low given the low prevalence of the variant
[minor allele frequency (MAF) in European origin popu-
lations: 2–5% (23,24,36,37)].
Strengths and limitations
It is unlikely that genotype data missing for 6000 women
would introduce selection bias. Empirical evidence suggests
that genotype frequencies are the same for general-population
versus selected samples in the UK (the British 1958 birth
cohort versus British blood donors from the Wellcome Trust
Case–Control Consortium) (38), and that genotypes display
no more correlation with socioeconomic, lifestyle and physio-
logical phenotypes than expected because of chance (39).
Moreover, based on our data we found a lack of association
Figure 1. Association of variation at 10 SNPs in ADH and alcohol drinking
(additive model). The two horizontal dotted lines refer to a nominal level of
statistical significance (P ¼ 0.05) and a conservative Bonferroni correction,
based on 30 tests—10 SNPs and 3 outcomes (P ¼ 0.05/30 ¼ 0.0017).
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of genotypes with socioeconomic and highly socially-
patterned factors such as smoking.
We considered the possibility of hidden population sub-
structure explaining the main result for rs1229984. This
variant is one of the most ethnically stratified, exhibiting a
wide range of MAFs: from 2–5% in Western European popu-
lations to 60–70% in North-East Asia (40), and alcohol intake
is strongly culturally-dependent (41). For this reason, we
limited the analyses to women of self-reported white ethnicity
and conducted sensitivity analyses by further excluding
women reporting at least one parent of non-white ethnicity
or likely to be ‘non-white’ based on ancestry-informative
markers genotype or self-reported Jewish faith, yet results
were unchanged. The lack of genome-wide data on this
sample prevented us from running further checks.
Chance is an unlikely explanation of our results. The choice
of the candidate variants was informed by a strong biological
prior, and for rs1229984, this was in fact an attempt to repli-
cate the association with alcohol intake seen in different con-
texts. The sample size was large, even by the standards of
genetic association studies. The power to detect effect sizes
like the ones observed for rs1229984 comparing A allele
Table 2. Association of variation at 10 SNPs in ADH and alcohol drinking (additive model)
SNP rs-number Weekly intake before pregnancy Weekly intake in first trimester Binge drinking during
pregnancy
ORa (95% CI) P-value ORb (95% CI) P-value ORc (95% CI) P-value
rs4699714 1.07 (0.99, 1.15) 0.084 1.01 (0.91, 1.12) 0.879 1.07 (0.97, 1.18) 0.180
rs3762894 0.96 (0.88, 1.05) 0.349 1.04 (0.91, 1.19) 0.553 1.04 (0.93, 1.17) 0.486
rs4148884 1.00 (0.89, 1.13) 0.947 0.99 (0.83, 1.18) 0.935 0.99 (0.85, 1.16) 0.894
rs2866151 1.10 (1.03, 1.17) 0.006 0.99 (0.90, 1.10) 0.908 1.01 (0.93, 1.11) 0.775
rs975833 0.97 (0.90, 1.04) 0.394 1.07 (0.95, 1.20) 0.254 1.02 (0.92, 1.13) 0.708
rs1229966 0.93 (0.87, 0.99) 0.032 1.02 (0.92, 1.13) 0.716 1.04 (0.95, 1.14) 0.431
rs2066701 0.95 (0.88, 1.02) 0.165 1.01 (0.91, 1.13) 0.841 1.00 (0.91, 1.10) 0.970
rs4147536 0.93 (0.86, 1.01) 0.073 0.98 (0.87, 1.10) 0.708 0.89 (0.80, 1.00) 0.045
rs1229984 0.69 (0.56, 0.86) 0.001 0.78 (0.53, 1.13) 0.192 0.55 (0.38, 0.78) 91024
rs284779 1.03 (0.96, 1.10) 0.398 1.08 (0.98, 1.20) 0.105 1.07 (0.98, 1.17) 0.148
aOdds ratio (OR) of drinking 7 units/week versus 1–6 units/week or 1–6 units/week versus ,1 unit/week before pregnancy, from ordinal logistic regression.
bOdds ratio of drinking 1 units/week versus ,1 unit/week in first trimester of pregnancy, from logistic regression.
cOdds ratio of drinking 4 units per drinking occasion (binge drinking) around week 18 of gestation, from logistic regression.
Figure 2. Linkage disequilibrium across the 10 ADH SNPs on chromosome 4 calculated as r2, from Haploview (ALSPAC mothers data).
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carriers versus non-carriers was 76% for binge drinking
during pregnancy and 80% for drinking cessation. Moreover,
over-conservative Bonferroni corrections and Bayesian
models were used in the first part of the analyses, both
accounting for multiple testing. However, the limited phenoty-
pic variation in this sample compared with previous studies
(23,24) (approximately 1 versus 3 drinks/week on average
for women) could reduce the power to detect associations of
alcohol use with other genetic variants with less marked
effects.
The usual concern with self-reported alcohol intake is
underreporting, both for general population samples (42) and
pregnant women (8). However, underreporting is unlikely to
be differential by genotype (under the null hypothesis of no
effect on alcohol consumption) and it affects higher intake cat-
egories more than moderate and low intake. It is unlikely that
under-reporting could explain the observed results, as the
heavier drinkers without the A allele could underreport their
consumption and declare similar intakes to the A allele car-
riers, introducing a bias towards the null. Quantity and fre-
quency questions were used to derive pre-pregnancy weekly
intake, shown to be generally valid (43) and reliable (44).
Levels of pre-pregnancy drinking reported by ALSPAC par-
ticipants included in this analysis were considerably lower
compared with average alcohol intake of UK women aged
25–34 (45), a likely reflection of intentional behavioral
change in preparation for the pregnancy. Figures on alcohol
consumption during pregnancy were higher than those from
surveys from the USA (46) and Sweden (34) showing that
12 and 30% of women reported consuming alcohol during ges-
tation. Here the figure was 55%, of which only 14% reported
drinking more than one drink weekly. Limited data are avail-
able on the prevalence of prenatal binge drinking, but a recent
French study reported 14% of women consuming five or more
drinks on one occasion during pregnancy (47), which is similar
to our figure of 17% for consuming four or more drinks,
whereas a US study found only 2% of pregnant women
binge drinking (46).
Comparison with published literature
Rs1229984 is a non-synonymous variant thought to have a
functional role. In vitro studies predicted up to 40 times
higher enzymatic activity comparing carriers versus non-
carriers of the A allele (26), resulting in faster accumulation
of plasma acetaldehyde. This would be aversive, and it is
the principle of action of the drug disulfiram, used for treating
chronic alcohol dependence (http://www.bnf.org/bnf/bnf/
current/3687.htm). However, the evidence for in vivo effects
is limited, possibly because of lack of power arising from a
combination of small sample sizes and low prevalence of
the variant. A study conducted among 109 Jewish university
Table 3. Association between alcohol consumption before and during pregnancy and the rs1229984A allele (ADH1B) among ALSPAC mothers—dominant
effect
Time period Absolute number Proportion carrying rare A allele, % Odds ratio (95% CI) P-value
Likelihood of abstaining
Before pregnancy Yes 498 6.6 1.47 (1.01, 2.13)a 0.043
No 6607 4.6
First trimester Yes 3167 5.8 1.55 (1.24, 1.93)a 0.0001
No 3923 3.9
Consumption levels among drinkers
Before pregnancy ,1 drink/week 2713 5.8
1–6 drinks/week 3229 4.1 0.67 (0.54, 0.84)b 0.0005
7þ drinks/week 836 3.4
First trimester ,1 drink/week 2853 4.2
1þ drinks/week 1170 3.3 0.77 (0.53, 1.12)b 0.171
aOdds ratio of abstaining versus drinking.
bOdds ratio of 1 units/week versus ,1 unit/week.
Table 4. Association between quitting drinking in pregnancy and the rs1229984A allele (ADH1B) among 6,889 ALSPAC mothers drinking before pregnancy—
dominant effect
Gestational period No quitted drinking/No still drinking Model 1a P-value Model 2b P-value
OR (95% CI) OR (95% CI)
First trimester 2680/3911 1.52 (1.21, 1.91) 0.0004 1.42 (1.12, 1.80) 0.004
18 weeks 3013/3468 1.23 (0.98, 1.56) 0.076 1.12 (0.88, 1.43) 0.366
32 weeksc 2614/1441 1.45 (1.06, 1.98) 0.021 1.28 (0.91, 1.81) 0.155
aModel 1 is the unadjusted effect of carrying the allele on the odds of quitting drinking.
bModel 2 is the effect of carrying the allele on the odds of quitting drinking, adjusted for the amount of alcohol drunk before pregnancy (,1 unit/week, 1–6 units/
week, 7 units/week).
cData only available for 4055 mothers.
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students in the USA (MAF ¼ 18.5%), reported that carriers of
the A allele exhibited higher alcohol elimination rates (48).
However, this locus contributed little to the total variance
explained by genetic variation in the whole ADH region in a
study of blood and breath ethanol levels among 412 Australian
twins (27), and similarly a larger and more recent study of
ADH variation and alcohol metabolism among 812 Australian
twins and relatives (MAF ¼ 3.5%) could not find sufficient
evidence for an effect of rs1229984 on blood or breath
ethanol concentrations (22). One study from Japan, where
the A allele is extremely prevalent (MAF ¼ 53%), failed to
detect an effect on blood levels of acetaldehyde following
light drinking (N ¼ 68) (49), but another reported that
extreme levels of drinking in alcoholics (N ¼ 80) gave rise
to higher blood ethanol and to a lesser extent blood acet-
aldehyde levels the morning after heavy drinking for carriers
of the ancestral G allele (slower metabolizers) (29).
The role of rs1229984 on alcohol phenotypes in non-Asian
population samples has been studied before, especially in
relation to dependence (23–25,50–52). In addition, a
number of studies consistently reported associations between
the A allele and reduced alcohol consumption (23–25,53–
57), as well as higher level of response to alcohol (58).
Most of the samples studied were relatively small (i.e.
,2000) (25,53–58). One exception is a study of 9000
Danes presenting evidence of increased alcohol consumption
in men not carrying the A allele (OR of heavy drinking for
G allele homozygotes versus heterozygotes: 3.1, 95% CI:
1.7, 5.7) (24). Another is a recent study from Australia exam-
ining 50 ADH polymorphisms in association with alcohol
intake, confirming rs1229984 as their top hit for most
alcohol drinking measures and alcohol-related reactions,
with the association between the A allele and reduced
overall alcohol consumption approaching ‘genome-wide’
levels of statistical significance (P-value ¼ 8.9  1028) (23).
The above results cannot be directly combined, mainly
because of incomplete reporting (P-values but no effect esti-
mate) and heterogeneity of populations and alcohol pheno-
types presented. However, consistency of the direction of
association across all studies as well as P-values from the
largest studies offer reassurance and strengthen the evidence
supporting a role of this SNP in influencing alcohol consump-
tion (sample results from the above cited studies are presented
in Supplementary Material, Table S6 available online).
Our study adds at least two important results to the existing
literature: women carrying the rs1229984 A allele are less
likely to report episodes of binge drinking during pregnancy
and they are more likely to report quitting alcohol during
the first trimester. The first finding is in line with previous evi-
dence, and extends this to the extremely sensitive time of preg-
nancy, when alcohol consumption has several potential
adverse effects on the fetus (10). The association with drinking
cessation is an entirely new result. Whether metabolic changes
occurring in pregnancy interact with the effect of the variant,
or whether the increased odds of quitting alcohol are due to
residual confounding by usual (pre-pregnancy) alcohol
intake, we cannot tell.
With the exception of a recent Australian twin study (23),
no other study has explored the association between
alcohol intake and variation across the ADH region beyond
the classical ADH1B and ADH1C variants. Most of the evi-
dence relating alcohol behavior to ADH variation in non-Asian
populations comes from three fine-mapping studies limited to
the alcoholism phenotype (37,52,59), whose results confirmed
a role for variation in ADH1B (37,52,59), and suggested one
for the ADH4 gene (37,52), replicating a previous study
(60). The only data on ADH4 comparable with this study is
an association signal for maximum number of drinks for
rs3762894, independent of rs1229984 (23). We could not
replicate this result when looking at binge drinking during
pregnancy, however, a full comparison is hindered because
effect estimates are not presented in the Australian publication
(23).
Variation in ADH7 has been implicated in the early stages
of alcohol metabolism (22), however, it is unclear how this
affects drinking propensity. A large recent study showed
strong evidence of gene  environment interaction between
the non-synonymous SNP rs1573496 and alcohol intake for
risk of upper aerodigestive tract cancers (61). This SNP has
also been shown to be associated with alcohol dependence
(52) [not in (59)]. A SNP in complete LD with rs1573496
(http://www.hapmap.org/cgi-perl/gbrowse/hapmap_B35/)
(62), rs971074, had also been associated with alcohol depen-
dence (52), but other studies failed to confirm the association
with either dependence (23,37,59), or with alcohol use and
adverse reactions (23). In agreement with these results,
the present study does not find evidence of association
between ADH7 variation and alcohol drinking before or
during pregnancy.
Few studies have reported on the association between
alcohol phenotypes and ADH1A polymorphisms, perhaps
reflecting the current belief that ADH1A enzymes are most
active in ethanol metabolism during fetal and early life, gradu-
ally losing function in adulthood (63). One of the fine-mapping
studies on ADH variants and alcohol dependence reported
signals for three ADH1A SNPs (52). For two of these SNPs,
typed in the present study, we found very modest signals for
drinking before pregnancy, in line with published evidence of
association between rs3819197 (in strong LD with one of our
SNPs) and alcohol consumption (23).
Conclusion and implications for future research
In conclusion, we propose the ADH1B variant rs1229984 as a
candidate genetic instrument to study the offspring effects of
maternal alcohol drinking, in European origin populations.
The association of this SNP with alcohol has been established
in several adult populations (23,24). Here and for the first
time, we present evidence that this effect exists also just
before and during pregnancy. However, replication of the
present findings in an independent sample is warranted for
the ultimate validation of the proposed instrument. A compar-
able approach to ‘instrument identification’ has been adopted
successfully by Freathy and colleagues, showing that a nic-
otine receptor gene variant predicts smoking cessation
during pregnancy (64).
The time around conception and the first trimester are cru-
cially sensitive periods, and the consequences of patterns of
drinking that can expose the fetus to high ethanol blood
concentrations are of particular concern (9). The uncertainty
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on longer-term effects of in utero exposure to ethanol into child-
hood and even adulthood arises from unreliable reporting of
alcohol intake leading to measurement error, as well as residual
confounding typical of standard observational studies. For
example, it has been suggested that up to 1% of all children
could suffer impaired neurodevelopment as a consequence of
prenatal alcohol exposure, but solid evidence is lacking (2).
This highlights the importance of using alternative study
designs that control for some or all of these problems, and
finally allow interpreting association as causation.
Natural experiments such as studies comparing differen-
tially exposed siblings (65) or exposed adoptees with natural
offspring have the potential to reduce biases and confounding
found in more traditional observational studies, although
measurement error remains an issue. Mendelian randomization
is one such natural experiment, with the additional advantage
of being free from alcohol assessment problems. Causal infer-
ence is enhanced by studying genetic markers that are specifi-
cally associated with the exposure of interest, but not with
other socially-patterned risk factors because genotypes are
randomized at conception, and clearly they can be measured
objectively (66).
In this light, our initial validation of a candidate genetic
instrument that predicts lower risk of binge drinking and
higher likelihood of giving up alcohol early in gestation, and
allows causal inference, takes on a significant public health
importance. Implications of the present work are that several
phenotypic outcomes could be studied in association with pre-
natal alcohol exposure, provided maternal ADH1B genotype is
available. For example, we have estimated through simu-
lations that in an instrumental-variable analysis using
rs1229984 as the genetic instrument, approximately 6000
mother–child pairs would be required to find evidence of a
causal association between alcohol consumption and a school-
based performance score at age 11 (Key Stage 2—http://en.
wikipedia.org/wiki/Key_Stage_2) at a 5% significance level,
assuming a small change of as little as 0.20 standard devi-
ations in the log-transformed outcome comparing A-allele car-
riers to non-carriers.
These results confirm the existence of a modest genetic con-
tribution to drinking behavior around the time of pregnancy.
However, they do not suggest that advice on alcohol drinking
during pregnancy should differ according to individual
genotype.
MATERIALS AND METHODS
Participants
The ALSPAC is a population-based longitudinal study that
recruited 80–90% of pregnant women living in Avon (the
English county with Bristol as main urban center) with
expected delivery date between April 1991 and December
1992 (67). Women of white ethnic origin participating in
ALSPAC were eligible for the study reported in this article if
they had provided a biological sample for DNA extraction,
returned a questionnaire at 18–20 weeks’ gestation, and com-
pleted the question on pre-pregnancy alcohol consumption. Eth-
nicity was largely available from self-reported data (N ¼ 7359,
90% of those genotyped). For those with missing self-reports
but available genotype data (N ¼ 601, 7%), white or non-white
ethnicity was imputed by regressing the offspring’s ethnicity as
well as genotype of five genetic ancestry-informative markers
with established population-specific allelic distributions—
rs713598 and rs1726966 in TAS2R38 (68), rs4988235 in
MCM6 (69), A44871G in ASPM (70) and rs930557 in
MCPH1 (70).
Supplementary Material, Fig. S1 available online describes
the flow of participants from recruitment into ALSPAC to final
inclusion in the current analyses.
Data on alcohol and related phenotypes
Mothers completed several questionnaires at enrolment,
throughout pregnancy and during their offspring’s infancy
and childhood. In a questionnaire completed at week 18 of
gestation, they were asked to recall their alcohol consumption
just before the current pregnancy, during the first trimester and
in the previous 2 weeks or at the time when they first felt the
baby move. Instructions specified that one drink was equival-
ent to 1 unit (8 g) of alcohol, and one pint of beer to 2 units.
Response categories for these questions were: never,
,1 unit/week, 1 units/week, 1–2 units/day, 3–9 units/day,
10 units/day. After excluding never drinkers, the last three
categories were grouped together. Thus three categories
were formed to create the variable ‘drinking before preg-
nancy’, whereas for ‘drinking during first trimester’ only two
categories were formed (,1 unit/week and 1 units/week),
after excluding those who stopped drinking. Around week
32 of gestation, women were asked about their average
weekday and weekend alcohol consumption, from which
weekly alcohol intake was derived. However, attrition was
high (41%) and the format of this variable was different
from the other alcohol drinking variables at previous time-
points, and therefore it was not used in formal association ana-
lyses. Drinking patterns were assessed in a separate question,
included in the questionnaires at week 18 of gestation, which
asked about the number of days in the previous 4 weeks that
the mother had consumed at least 4 units of alcohol [defined
as ‘binge drinking’ occasions for the purpose of this study
(71)]]. Response categories were 0, 1–2, 3–4, 5–10 or 10
days. For the analyses, consuming at least 4 units of alcohol
on one or more days around week 18 was considered ‘binge
drinking during pregnancy’. Drinking cessation at various
time-points was defined as non-drinking at those time-points,
for women who were drinking before the index pregnancy.
Maternal age at delivery was derived from date of birth, col-
lected at enrollment. Maternal and socio-demographic vari-
ables obtained during pregnancy were categorized for
analysis: family social class (based on the highest occupation
among the woman and her partner and dichotomized into
manual versus otherwise, using the 1991 British Office of
Population and Census Statistics classification); highest level
of maternal education (secondary level academic qualifica-
tion—‘O’ level—or higher versus lower); smoking before
the current pregnancy (yes versus no); heavy smoking before
the current pregnancy (15 cigarettes/day versus fewer);
overweight before the current pregnancy [body mass index
(BMI) 25 versus less]. Questions on nausea and recent
changes in consumption of coffee, tea, cola, alcohol and
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cigarettes were included in the questionnaire completed in the
first trimester of gestation. On the basis of questionnaires com-
pleted by partners themselves, data were derived on partner’s
alcoholism (ever suffered from alcoholism versus never) and
alcohol drinking habits (1 units/day versus less, before the
pregnancy).
Further details are included in the study protocol (67) or can
be found on the ALSPAC website (http://www.alspac.bris.ac.
uk). Ethical approval was obtained from the ALSPAC Law
and Ethics Committee (IRB 00003312) and the Local
Research Ethics Committee.
Genotyping
Ten SNPs were selected based on published evidence of func-
tionality (i.e. rs1229984 in ADH1B) or association with
alcohol-related phenotypes, and typed as part of an investi-
gation of the role of maternal drinking on childhood growth
and development in ALSPAC. Efforts were made to choose
a set of independent common polymorphisms (MAF  0.05
for all except rs1229984). Coverage of ADH1A in particular
(3 SNPs), whose related enzymes are most active during
fetal and early life (63), reflects the scope of the study for
which the genotyping was done. The prior for inclusion in
the study for each SNP was not assessed through a formal
meta-analysis of published associations, which was impossible
because of the limited evidence presented. Rather, we looked
for consistency of association across the different studies that
reported results for a particular SNP, as well as evidence of
functionality. We acknowledge that this strategy has the short-
coming of not being fully replicable.
DNA was extracted from peripheral blood taken during
pregnancy as described previously (72). SNPs were genotyped
by KBioscience (http://www.kbioscience.co.uk) using the
KASPar chemistry, a competitive allele-specific PCR system
using FRET quencher cassette oligos (http://www.kbioscience
.co.uk/genotyping/genotyping-chemistry.htm). Blind dupli-
cates, plate-identifying repeat samples and Hardy–Weinberg
equilibrium tests were used as quality control checks.
Statistical analyses
Analyses were restricted to women of white ethnic origin.
Associations between the SNPs and alcohol intake variables
were tested in univariable models assuming additive effects
of rare alleles. For SNPs with MAF , 0.05, rare homozygotes
and heterozygotes were analyzed together and a dominant
effect was assumed. Logistic regression was used for
binary outcomes and ordinal logistic regression for ordered
categorical variables (e.g. average weekly drinking before
pregnancy—,1 unit/week, 1–6 units/week, 7 units/week).
Despite our efforts to select variants that are as independent
of each other as possible, not all of the pair-wise correlations
would be null. This means that signals from the crude analysis
could have been confounded by some other SNPs because of
LD, which is high in the ADH region. In order to identify inde-
pendent genetic effects, Bayesian models were fitted to the
data for each of the three alcohol phenotypes. These models
account for LD patterns in the data and also for multiple
testing. SNPs are kept in the model based on their probability
of explaining variation in the outcome in relation to the per-
formance of all the other SNPs, which can enter the model
individually or in combination (73). The variable selection
follows a reversible-jump algorithm based on a binomial
prior distribution, with parameter for the number of trials
being the total number of predictors included in the model,
and the parameter for probability of ‘success’ equal to 0.5
(73). This ensures all possible models are equally likely a
priori. Ten thousand iterations were completed, with the first
5000 specified as burn-in.
Top hits identified in the first phase of analyses were
regressed against the likelihood of drinking cessation at differ-
ent time-points during pregnancy, in crude analyses as well as
adjusting for pre-pregnancy alcohol consumption levels (likely
on the causal pathway).
To empirically assess the specificity of the ADH1B
variant-alcohol intake associations, the OR of selected partici-
pant’s and partner’s characteristics were derived comparing
carriers of the rs1229984 A allele versus non-carriers, and
those drinking ,1 unit/week before pregnancy versus those
drinking 1 units/week (Supplementary Material, Table S4).
Similarly, since abstaining in the first trimester could be
explained by symptoms of nausea and food aversions, we
looked at these in association with rs1229984 (Supplementary
Material, Table S5).
Since rs1229984 shows extreme stratification in different
populations worldwide (40), and alcohol drinking follows cul-
tural patterns (41), there is a possibility of residual confound-
ing by population substructure, even if the sample analyzed
only included women reporting white/European ethnicity. To
assess this, we conducted sensitivity analyses by further
excluding women following two more conservative definitions
of ‘white ethnicity’: one based on the woman’s reported par-
ental ethnicity, and her own; another based on a set of
ancestry-informative genetic markers. Finally, we repeated
the analyses after excluding all women reporting to be of
Jewish religious faith, as a proxy for Jewish ancestry/ethnicity.
This was done since the prevalence of the A allele is much
higher in populations from West Asia including Jews from a
variety of regions (74), who might also drink less than other
individuals of European ancestry that would equally describe
themselves as ‘white’.
Statistical analyses were performed in Stata 10 and
WinBugs (75). Pair-wise LD across the 10 SNPs (as r2) was
computed using Haploview (76).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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